Stereotaxis
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1990-01-01
- Employees
- 122
- Market Cap
- -
- Website
- http://www.stereotaxis.com
- Introduction
Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.
Stereotaxis' Magbot Magnetic Ablation Catheter Approved in China
• Stereotaxis received regulatory approval in China for its Magbot magnetic navigation ablation catheter, designed for minimally invasive cardiac procedures.
• The approval follows recent clearance for Stereotaxis' Genesis robotic magnetic navigation system, expanding its footprint in the Chinese market.
• Magbot, developed with MicroPort EP, integrates with robotic systems for precise navigation and real-time 3D cardiac modeling.
• NMPA approved Magbot for treating drug-resistant persistent AFib, atrioventricular nodal reentrant tachycardia, and atrioventricular reentrant tachycardia.
© Copyright 2025. All Rights Reserved by MedPath